National Health Investors (NYSE:NHI) received a $75.00 price target from investment analysts at SunTrust Banks in a research report issued on Monday. The brokerage currently has a “hold” rating on the real estate investment trust’s stock. SunTrust Banks’ price objective suggests a potential upside of 5.77% from the stock’s previous close.
A number of other equities analysts have also commented on the stock. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a report on Thursday, September 28th. Stifel Nicolaus reiterated a “buy” rating and issued a $82.00 price objective on shares of National Health Investors in a report on Wednesday, October 4th. Mizuho reiterated a “hold” rating and issued a $82.00 price objective on shares of National Health Investors in a report on Wednesday, October 4th. BMO Capital Markets reiterated a “hold” rating and issued a $80.00 price objective on shares of National Health Investors in a report on Wednesday, October 18th. Finally, Capital One Financial initiated coverage on shares of National Health Investors in a report on Monday, October 23rd. They issued an “equal weight” rating on the stock. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $80.63.
National Health Investors (NYSE NHI) traded up $1.11 during trading hours on Monday, hitting $70.91. 225,074 shares of the company traded hands, compared to its average volume of 231,155. The company has a debt-to-equity ratio of 0.84, a current ratio of 12.72 and a quick ratio of 12.72. The firm has a market cap of $2,950.00, a price-to-earnings ratio of 17.73, a price-to-earnings-growth ratio of 3.22 and a beta of 0.59. National Health Investors has a 1-year low of $68.96 and a 1-year high of $81.60.
Several institutional investors and hedge funds have recently added to or reduced their stakes in NHI. BlackRock Inc. increased its position in shares of National Health Investors by 6.6% in the 2nd quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock worth $280,927,000 after purchasing an additional 218,482 shares during the last quarter. Allianz Asset Management GmbH increased its position in shares of National Health Investors by 57.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 394,800 shares of the real estate investment trust’s stock worth $30,514,000 after purchasing an additional 144,650 shares during the last quarter. State Street Corp increased its position in shares of National Health Investors by 8.5% in the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock worth $79,133,000 after purchasing an additional 78,355 shares during the last quarter. Vanguard Group Inc. increased its position in shares of National Health Investors by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock worth $498,323,000 after purchasing an additional 72,518 shares during the last quarter. Finally, Employees Retirement System of Texas increased its position in shares of National Health Investors by 353.3% in the 2nd quarter. Employees Retirement System of Texas now owns 81,600 shares of the real estate investment trust’s stock worth $6,463,000 after purchasing an additional 63,600 shares during the last quarter. 70.12% of the stock is owned by institutional investors.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.